HOB Biotech Group Corp Ltd Class A 688656
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥21.89
- Day Range
- ¥21.68–22.40
- 52-Week Range
- ¥17.93–41.58
- Bid/Ask
- ¥21.78 / ¥21.84
- Market Cap
- ¥1.38 Bil
- Volume/Avg
- 275,290 / 339,924
Key Statistics
- Price/Earnings (Normalized)
- 33.31
- Price/Sales
- 3.52
- Dividend Yield (Trailing)
- 1.83%
- Dividend Yield (Forward)
- 1.83%
- Total Yield
- 1.83%
Company Profile
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 550
- Website
- http://www.hob-biotech.com
Comparables
Valuation
|
Metric
|
688656
|
603122
|
300439
|
|---|---|---|---|
Price/Earnings (Normalized) | 33.31 | 50.52 | 15.51 |
Price/Book Value | 1.68 | 1.84 | 1.22 |
Price/Sales | 3.52 | 1.87 | 1.81 |
Price/Cash Flow | 12.98 | 27.37 | 5.82 |
Price/Earnings
688656
603122
300439
Financial Strength
|
Metric
|
688656
|
603122
|
300439
|
|---|---|---|---|
Quick Ratio | 1.01 | 3.36 | 2.58 |
Current Ratio | 1.81 | 4.37 | 3.11 |
Interest Coverage | 21.54 | 10.36 | 31.84 |
Quick Ratio
688656
603122
300439
Profitability
|
Metric
|
688656
|
603122
|
300439
|
|---|---|---|---|
Return on Assets (Normalized) | 4.46% | 2.88% | 5.83% |
Return on Equity (Normalized) | 5.28% | 3.74% | 7.58% |
Return on Invested Capital (Normalized) | 4.97% | 3.06% | 7.14% |
Return on Assets
688656
603122
300439
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Hfknjcm | Fwpgd | $183.1 Bil | |||
| Stryker Corp
SYK
| Cvpvvfcxrc | Hxy | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Mjntrckl | Wbsjj | $110.1 Bil | |||
| Medtronic PLC
MDT
| Bmwkcrv | Pdkxzt | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Kdqllrcq | Cbmyf | $37.6 Bil | |||
| DexCom Inc
DXCM
| Fsdhtsftgy | Bdb | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Fnqhxmkw | Dbwhy | $24.1 Bil | |||
| Steris PLC
STE
| Ykkcqhmwh | Qsnvk | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Wxlnkdshg | Psbz | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Tbqwdwxvf | Cmmwwj | $16.6 Bil |